1 report

  • 01/03/2017: Cryoport Supports Gradalis' Vigil Platform in Clinical Trials for Autologous Immunotherapies for Multiple Cancers
  • Gradalis Raises US$24 Million In Series B Financing

Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals Inc, is a biopharmaceutical company that provides development and commercialization of therapies for the treatment of cancer.The company’s developmental pipeline comprises of candidates for various cancer indications which include ovarian, breast, melanoma,...

  • Cancer
  • Healthcare
  • Pathology
  • United States
  • Gradalis, Inc.